View Author
patient treatment study level somatostatin therapy receptor effect insulin concentration cortisol endocrinol ghrelin acromegaly tumor carcinoid analogue glucose disease hormone 177 lu-octreotate tumour adenomas administration group somatostatin analogues month lu-octreotate result endocrinology subject octreotide metab portal liver secretion response igf-i cushing baseline expression growth peg-v corticotroph serum journal surgery grade t-cell corticotroph adenomas change tissue number neuroendocrine blood syndrome value clin endocrinol subtype table obestatin som 230 cancer adenoma release ivgtt saline remission acromegalic patients tumours morbidly metabolism score range plasma control octreotide lar sst 5 analysis signi
10 Most Recent Publications
|
Morbidly obese human subjects have increased peripheral blood CD4 + T cells with skewing toward a Treg- and Th2-dominated phenotype
(Article)
Weerd, K. van der Dik, W.A. Lelij, A.J. van der Staal, F.J.T. Hagen, P.M. van Schrijver, B. Schweitzer, D.H. Langerak, A.W. Drexhage, H.A. Kiewiet-Kemper, R.M. Aken, M.O. van Huisstede, A. van Dongen, J.J.M. van |
2012-02-01
|
|
Acute effects of acylated and unacylated ghrelin on total and high molecular weight adiponectin in morbidly obese subjects
(Article)
Kiewiet-Kemper, R.M. Hazell, M.J. Aken, M.O. van Weerd, K. van der Visser, J.A. Themmen, A.P.N. Lely, A.J. van der |
2011-06-01
|
|
Effects of methimazole on the elimination of irinotecan
(Article)
Bol, J.M. van der Visser, T.J. Loos, W.J. Jonge, M.J.A. de Wiemer, E.A.C. Aken, M.O. van Planting, A.S.Th. Schellens, J.H. Verweij, J. Mathijssen, R.H.J. |
2011-01-01
|
|
Biochemical predictors of outcome of pituitary surgery for cushing's disease
(Article)
Alwani, R.A. Herder, W.W. de Aken, M.O. van Berge, J.H. van den Delwel, E.J. Dallenga, A.H.G. Jong, F.H. de Lamberts, S.W.J. Lely, A.J. van der Feelders, R.A. |
2010-03-01
|
|
Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetes
(Article)
Kiewiet-Kemper, R.M. Aken, M.O. van Lely, A.J. van der Weerd, K. van der Uitterlinden, P. Themmen, A.P.N. Hofland, L.J. Rijke, Y.B. de Delhanty, P.J.D. Ghigo, E. Abribat, T. |
2009-11-27
|
|
Medical therapy of acromegaly: Efficacy and safety of somatostatin analogues
(Article)
Feelders, R.A. Hofland, L.J. Aken, M.O. van Neggers, S.J.C.M.M. Lamberts, S.W.J. Herder, W.W. de Lely, A.J. van der |
2009-11-04
|
|
Effects of therapy with [177Lu-DOTA0,Tyr 3]octreotate on endocrine function
(Article)
Teunissen, J.J.M. Krenning, E.P. Jong, F.H. de Rijke, Y.B. de Feelders, R.A. Aken, M.O. van Herder, W.W. de Kwekkeboom, D.J. |
2009-06-03
|
|
Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas
(Article)
Bruin, C. de Pereira, A.M. Hofland, L.J. Feelders, R.A. Romijn, J.A. Roelfsema, F. Sprij-Mooij, D. Aken, M.O. van Lelij, A.J.D. van Herder, W.W. de Lamberts, S.W.J. |
2009-04-01
|
|
Cushing's syndrome due to ectopic ACTH production by (neuroendocrine) prostate carcinoma
(Article)
Alwani, R.A. Neggers, S.J.C.M.M. Klift, M. van de Baggen, M.G.A. Leenders, G.J.L.H. Aken, M.O. van Lely, A.J. van der Herder, W.W. de Feelders, R.A. |
2009-01-01
|
|
Bolus administration of obestatin does not change glucose and insulin levels neither in the systemic nor in the portal circulation of the rat
(Article)
Kiewiet-Kemper, R.M. Gauna, C. Aken, M.O. van Zande, B. van de Lely, A.J. van der |
2008-12-01
|
